Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Post by FredTheVoiceon Oct 22, 2018 3:05pm

137 Views

Post# 28850267

Shorts unhappy; management happy.

If you are long and if you are part of the management team; you are happy. Because you feel that everything is on track; you are happy because of the deal at 14$, and being at 100% owner of EGRIFTA, and TROGARZO is gaining momentum in sales.

If you are a short that tough that shares had touch a bottom at 11$.......(I bough a couple more at these level myself), than you are unhappy with good reasons to be. But, time will soon make you discover that it was a good idea to stand still.

I think management of TH know exactly what they are doing, and where they are going.....

FTV.

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario